EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sappanchalcone Attenuates Platelet Activation and Clot Retraction Through Coordinated Modulation of Cyclic Nucleotides and PI3K/MAPK Signaling Pathways

Ga Hee Lee, Jin Pyo Lee, Chang Eun Park, Dong-Ha Lee

Die Pharmazie · 2026

DOI: 10.31083/pharmazie54071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Die Pharmazie, 2026. Verfasst von Ga Hee Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Laboratory Science, Namseoul University, 31020 Cheonan, Chungcheongnam-do, Republic of Korea. Hauptthemen laut MEDLINE: Platelet Activation, Chalcones, Clot Retraction, MAP Kinase Signaling System. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Aberrant platelet activation is a major contributor to thrombotic disorders, prompting interest in naturally derived candidates that can safely regulate platelet function. Sappanchalcone, a chalcone-type flavonoid derived from Caesalpinia sappan L., has diverse biological activities; however, its effects on platelet activation and clot retraction remain unclear. This study evaluated the antiplatelet potential of sappanchalcone and its underlying mechanisms in human platelets.Methods:Washed human platelets and platelet-rich plasma were used to assess platelet activation and clot retraction, respectively. Samples were pretreated with sappanchalcone (16–128 μM, depending on the assay) and stimulated with collagen or thrombin. Platelet aggregation and cytotoxicity were assessed by light transmission aggregometry and lactate dehydrogenase (LDH) leakage assay. cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), and thromboxane B2 (TXB2) levels were quantified using enzyme-linked immunosorbent assay (ELISA) kits, and intracellular Ca2+ mobilization was measured by Fura-2/AM-based fluorescence analysis. Protein phosphorylation was examined by Western blotting, whereas integrin αIIbβ3–fibrinogen binding was analyzed by flow cytometry. Dense granule secretion was evaluated using adenosine triphosphate (ATP) luminescence and serotonin ELISA assays. Thrombin-induced clot retraction was quantified by ImageJ (v1.54k, U.S. National Institutes of Health, Bethesda, MD, USA)-based residual clot area analysis. Data are presented as mean ± standard deviation (SD) and analyzed by one-way analysis of variance (ANOVA) with Tukey–Kramer post hoc test (n = 4; p < 0.05).Results:Sappanchalcone concentration-dependently inhibited collagen-induced platelet aggregation, reducing aggregation from 83.0% to 10.7% at 128 μM, with a half-maximal inhibitory concentration (IC50) of 57.16 μM, without cytotoxicity. At 128 μM, sappanchalcone increased cAMP from 7.02 ± 0.85 to 11.96 ± 0.57 pmol/108 platelets and reduced Ca2+ mobilization from 711.97 ± 47.29 to 66.11 ± 6.83 nM. Vasodilator-stimulated phosphoprotein (VASP) Ser157 and Ser239 phosphorylation increased by 2.97- and 2.07-fold, respectively, whereas fibrinogen binding decreased from 74.43 ± 5.67% to 21.90 ± 1.25%. Phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 phosphorylation was reduced to 0.69-, 0.21-, 1.81-, 0.27-, and 0.49-fold, respectively. ATP secretion, serotonin release, TXB2 levels reflecting thromboxane A2 (TXA2) generation, cytosolic phospholipase A2 (cPLA2) phosphorylation, and thrombin-induced clot retraction were also suppressed.Conclusions:Sappanchalcone limits platelet activation, aggregation, and clot retraction by enhancing cyclic nucleotide-mediated inhibitory signaling and suppressing PI3K/Akt and mitogen-activated protein kinase (MAPK) phosphorylation. These findings provide mechanistic evidence supporting sappanchalcone as a potential naturally derived antiplatelet candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet ActivationChalconesClot RetractionMAP Kinase Signaling SystemPlatelet Aggregation InhibitorsHumansCyclic GMPCyclic AMPPlatelet AggregationPhosphatidylinositol 3-KinasesBlood PlateletsCalciumPhosphorylationSignal TransductionThromboxane B2Nucleotides, CyclicThrombinDose-Response Relationship, Drug

Stichwörter der Autor:innen

clot retractioncyclic AMPcyclic GMPmitogen-activated protein kinasesphosphatidylinositol 3-kinasesplatelet activationproto-oncogene proteins c-aktsappanchalcone

Substanzen

ChalconesCyclic GMPCyclic AMPsappanchalconePhosphatidylinositol 3-KinasesCalciumPlatelet Aggregation InhibitorsThromboxane B2Nucleotides, CyclicThrombin

Autor:innen und Institutionen

  • Department of Biomedical Laboratory Science, Namseoul University, 31020 Cheonan, Chungcheongnam-do, Republic of Korea.
  • Molecular Diagnostics Research Institute, Namseoul University, 31020 Cheonan, Chungcheongnam-do, Republic of Korea.

Zitieren

APA

Lee, G. H., Lee, J. P., Park, C. E., & Lee, D. H. (2026). Sappanchalcone Attenuates Platelet Activation and Clot Retraction Through Coordinated Modulation of Cyclic Nucleotides and PI3K/MAPK Signaling Pathways. Die Pharmazie. https://doi.org/10.31083/pharmazie54071

Vancouver

Lee GH, Lee JP, Park CE, Lee DH. Sappanchalcone Attenuates Platelet Activation and Clot Retraction Through Coordinated Modulation of Cyclic Nucleotides and PI3K/MAPK Signaling Pathways. Die Pharmazie. 2026. doi:10.31083/pharmazie54071

BibTeX
@article{Lee2026,
  author = {Lee, Ga Hee and Lee, Jin Pyo and Park, Chang Eun and Lee, Dong-Ha},
  title = {Sappanchalcone Attenuates Platelet Activation and Clot Retraction Through Coordinated Modulation of Cyclic Nucleotides and PI3K/MAPK Signaling Pathways},
  journal = {Die Pharmazie},
  year = {2026},
  doi = {10.31083/pharmazie54071}
}
Kostenlos starten →